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Sleep disturbance affects nearly 30 percent of breast cancer survivors and has 
consequences on quality of life. Pharmacologic treatment for sleep disturbance exists, 
however cancer survivors are seeking alternative ways to improve outcomes. There is a 
need to investigate treatment modalities for sleep disturbance and quality of life in this 
population. Qigong is a five-dimension-based mind-body therapy that has shown to 
improve sleep disturbance and quality of life. There has yet to be a randomized controlled 
trial comparing Qigong to an active control on sleep disturbance specifically for breast 
cancer survivors.  We propose that Qigong will be superior in improving sleep 
disturbance and quality of life in breast cancer survivors when compared to light 
exercise. Participants will be randomized to either Qigong or light exercise over twelve 
weeks. The findings will inform healthcare providers and assist them in managing 
symptoms that may improve quality of life in this population.  
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CHAPTER 1: INTRODUCTION 
1.1 BACKGROUND 
Breast cancer is the most commonly diagnosed cancer in females in the United 
States and the second most common cause of cancer-related death in females in the United 
States.1 With increasing early detection screening tools and successful treatment regimens, 
higher numbers of women are diagnosed with early-stage breast cancer every year and 
mortality rates are steadily declining.2,3 In developed nations, there is now a 90% 5-year 
survival rate for women with breast cancer and an almost 100% 5-year survival rate for 
those with localized disease.4 As of January 1, 2019, an estimated 8,781,580 female cancer 
survivors were living in the United States, with 3,861,520 of those being breast cancer 
survivors (BCS) specifically.4 Yet with this increase in survivorship comes an increase in 
patients presenting to their healthcare providers with side effects from treatment and long-
term comorbidities.4  
The choice of treatment for women diagnosed with breast cancer is dependent on 
cancer stage, tumor size and grade, number of involved lymph nodes, and status of hormone 
receptors.5 Surgery is usually the first choice of treatment for early-stage breast cancer and 
entails either breast-conserving therapy or mastectomy.6 Depending on the stage and extent 
of lymph node or other organ involvement, women may undergo adjuvant therapy or 
neoadjuvant therapy. Adjuvant therapy is systemic therapy using chemotherapy, endocrine 
therapy, and/or targeted therapy. Women with localized and earlier-staged disease are most 
likely to benefit from neoadjuvant therapy, therapy initiated before surgery; it has 
demonstrated better overall disease-free survival outcomes than surgery combined with 
adjuvant systemic therapy.6 
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With the treatment options available come multiple side effects including those 
affecting body physiology, mental health, and quality of life. Physiological side effects can 
include chronic pain, lymphedema, infertility, cognitive deficits, and cardiotoxicity.7-9 
Depression, anxiety, fatigue, and sleep disturbance are particularly pervasive in this 
population both during and after treatment, and are a result of a combination of the 
malignancy itself, treatment, and effects of treatment.10 Women undergoing treatment may 
experience depression and anxiety due to fear of recurrence, uncertainty of disease 
prognosis, fears of experiencing side effects, and worry of career and financial implications 
of the prognosis.7,11 One study found that 4.6% of a sample of 153 BCS met diagnostic 
criteria for post-traumatic stress disorder (PTSD) related to their breast cancer treatment as 
long as 20 years after diagnosis.11  
Fatigue has an estimated prevalence of anywhere from 28 to 91% in cancer patients 
and approximately 30% will experience persistent symptoms for years after treatment.5,12 
Fatigue in cancer patients is a subjective and persistent sense of exhaustion physically, 
emotionally, and/or cognitively that cannot be attributed to recent activity and is related to 
cancer or cancer treatment.12 There are many treatable contributing factors to fatigue in this 
population, a major one of which is sleep disturbance.12  
Sleep disturbance, the focus of this study, is nearly ubiquitous in the breast cancer 
population. Compared to patients with other forms of cancer, breast cancer patients tend to 
experience sleep disturbance more frequently, and the majority report it within the first year 
of diagnosis and treatment.13,14 In BCS, prevalence rates of sleep disturbance are estimated 
to be anywhere from 30 to 90%; close to that of fatigue rates in all cancer patients.13 Almost 
30% of BCS meet the criteria for insomnia which is defined as difficulty initiating sleep, 
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frequent awakenings, and an inability to return to sleep.13 This is almost twice the rate of 
sleep disturbance as seen in the general population.13 The types of sleep disturbances in BCS 
can vary widely and may include difficulty falling asleep, difficulty staying asleep, non-
restorative sleep, frequent nighttime awakenings, hypersomnolence, excessive daytime 
napping, sleep apnea, parasomnias, restless leg syndrome, and sleep-related movement 
disorders like sleepwalking.13,15,16 Untreated sleep disturbance in BCS has negative 
consequences on quality of life and well-being, and has been associated with comorbidities 
like hypertension.13 A 2014 study found that sleep disturbance in breast cancer patients with 
metastatic disease was associated with poorer survival outcomes and that participants 
reporting less objective sleep disturbance were found to have significantly lower mortality 
rates over six years.17  
The etiology of sleep disturbance in this population is multifactorial and not 
completely understood. The stress and anxiety associated with a cancer diagnosis in 
combination with the side effects of treatment are thought to be the primary precipitating 
factors.17 Physiologically, chronic low-grade inflammation and altered regulation of the 
autonomic nervous system have been implicated.18 The diagnosis of cancer itself has also 
been shown to alter the circadian rest-activity rhythm that normally dictates the sleep-
wake cycle due to changes in rhythmic secretions of cortisol.18 Additionally, recent 
evidence has found that sleep disturbance, fatigue, and depression tend to co-occur.16 One 
study found that insomnia was related to higher levels of fatigue, with a higher degree of 
insomnia predicting a higher level of fatigue.19 Because sleep disturbance is a strong 
contributing factor of fatigue, and because of the intertwining nature of these disorders, 
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treating sleep disturbance has implications for concurrent treatment of fatigue, anxiety, and 
depression as well.   
First-line treatment for sleep disturbance in BCS is usually either pharmaceutical 
therapy or psychotherapy, specifically Cognitive Behavioral Therapy for Insomnia (CBT-
I).15 Yet many cancer survivors have an increased desire to use complementary medicine 
(CM) therapies. Eighty-three percent of American cancer patients have reported the use of 
CM in addition to their standard medical therapies after diagnosis, and nearly 50% of BCS 
report annual use of mind-body interventions to improve their health.20,21 Exercise is an 
alternative treatment modality recommended by the National Comprehensive Cancer 
Network (NCCN) which has published guidelines for improvement in general sleep hygiene 
measures for cancer patients.14 Exercise has been shown to improve perceived global sleep 
quality in BCS and endometrial cancer survivors and has demonstrated improved outcomes 
of better sleep including fatigue, physical function, and quality of life in patients with 
multiple forms of cancer.14,22,23 Although the benefits of exercise are apparent, exercise is 
considered a unimodal intervention and lacks multimodality unique to meditative movement 
exercises such as Qigong, Tai Chi, and yoga that could have more extensive indications for 
the myriad of symptoms that contribute to sleep disturbance.24   
Medical Qigong is a traditional Chinese medicine practice that could serve as a CM 
modality option for BCS experiencing sleep disturbance. As a form of CM, Qigong is 
widely used in China in conjunction with traditional healing modalities like 
pharmaceuticals or surgery, working best through this synergy.25 The practice combines 
breathing, exercise, meditation, and body movements with the primary goal of manipulating 
the body’s energy, or “qi,” to improve physical, psychological, and spiritual health.26,27 
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Though the exact mechanisms of Qigong remain unknown, it is thought to improve 
homeostasis of the autonomic nervous system and to increase the production of endogenous 
melatonin, a hormone for sleep and circadian rhythms in the body.13,21,28 Slow, deep 
breathing has been implicated in reductions in oxidative stress, blood pressure, and bringing 
balance to the autonomic nervous system.29 Further, the combination of breathing with 
mindfulness and movement may contribute to improvement in emotional state, anxiety, and 
depression.29 Tai Chi is one of the most widely known forms of Qigong especially in the 
United States, but it differs from pure Qigong in that it is more choreographed and 
complex, while Qigong is traditionally more repetitive, gentler, and easier to learn.29 
Qigong is an accessible modality for both healthy adults and those living with 
chronic disease and the benefits appear to be widespread. The exercise component of 
Qigong is gentle and easy to learn, and requires less physical capacity when compared to 
traditional aerobic exercise, yoga, and even Tai Chi.13 Thus, it may be more accessible to 
our population who often suffer from multiple treatment effects and comorbidities, as well 
as those in our population who are older and would benefit from exercise that corresponds to 
age-related changes.26 Previous research has demonstrated adherence to conventional 
exercise being as low as 39% in cancer patients; while in the Women’s Healthy Eating and 
Living study, 70% of BCS adhered to Tai Chi or Qigong.29 Comparing the benefits of 
Qigong’s multimodal framework to the unimodal framework of aerobic exercise and 
exploring implications of its effects on sleep disturbance and quality of life could both add 
to the knowledge of this eastern-medicine practice and give BCS a more accessible 
treatment option to sustain a healthy life. 
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1.2 STATEMENT OF THE PROBLEM 
 Sleep disturbance is reported as a major source of distress in BCS and has 
negative effects on quality of life.30 Due to sleep disturbance being a result of multiple 
possible etiologies, it is difficult to identify the most effective method to manage it. CM 
modalities for treating sleep disturbance are becoming more desirable to BCS. Yet 
efficacy trials of alternative modalities are lacking to inform both patients and 
providers.21 Exercise is a unimodal non-pharmaceutical treatment option for sleep 
disturbance that has been shown to improve sleep and quality of life in BCS; however, 
for BCS with multiple comorbidities and increasing age, exercise is not always accessible 
and adherence may prove difficult.26,29 Qigong may be a more accessible and effective 
alternative.  
Because Qigong is based in Eastern medicine, some studies have lacked 
generalizability as samples have been restricted to locations in Asian countries.13,27 
Sample sizes of trials have been small and some studies lacked effective control groups 
or the presence of control groups at all, which threaten the validity of results.13,29 
Randomized controlled trials (RCT) comparing the multimodal benefits of Qigong 
compared to the unimodal benefits of exercise on sleep disturbance and quality of life are 
missing.29 There is a need to extend the literature with an RCT comparing Qigong with an 
active control, such as light exercise, in BCS to add treatment options and improve 
survivorship outcomes in this population.  
1.3 GOALS AND OBJECTIVES  
In this RCT, we aim to investigate the multidimensional effects of Qigong compared 
to light exercise in female BCS. We will accomplish this by looking at the pre- and post-
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intervention changes in five dimensions—physical, social, spiritual, emotional, and 
mental—with an emphasis on the physical dimension as measured by sleep disturbance. We 
hope to demonstrate the improved mind-body benefits of Qigong over conventional exercise 
and add to the literature regarding the efficacy of this more accessible option for mitigation 
of post-treatment sleep disturbance and decreased quality of life.  
Only BCS who meet the eligibility criteria will be enrolled in the trial. Participants 
will be randomly assigned to one of two groups: Qigong or light exercise. They will be 
followed weekly for 12 weeks. The main objective is to determine differences in mean 
change from baseline in self-reported sleep scores as measured by the Pittsburg Sleep 
Quality Index (PSQI) between groups. Secondary objectives include: 1) determining 
differences in mean change from baseline between groups in objective sleep parameters 
using a Fitbit wristband, 2) determining differences in mean change from baseline between 
groups in the four other dimensions—social, spiritual, emotional, and mental—measured by 
the Functional Assessment of Cancer Therapy- Breast (FACT-B) and the spirituality 
subscale of the FACT-B, the Functional Assessment of Chronic Illness Therapy- Spiritual 
Well-Being Scale (FACIT-Sp). 
1.4 HYPOTHESIS 
Among adult females within six months to five years past completion of primary 
treatment for primary breast cancer stages 0-III, there will be a statistically significant 
difference in sleep disturbance measured by mean change in sleep quality scores on the 
PSQI after 12 weeks of an instructor-led group Qigong course, as compared to instructor-
led light exercise through the integration of physical movement and meditative stress 




Primary breast cancer treatment: Surgery, radiation, chemotherapy, or endocrine 
therapy. 
Sleep disturbance: Difficulty initiating sleep, frequent awakenings, and an inability to 
return to sleep.13 A score of greater than 5 on the PSQI.31 
Medical Qigong/ Qigong: “qi” -energy flow or life energy, “gong” -achievement, work, 
or skill.23,27 A movement-based mind-body practice originating in China that combines 
slow, low-impact movement with meditation, breathing techniques, and mindful focus on 
the body, with a goal of manipulating the body’s energy (qi) for the benefit of physical, 
psychological, and spiritual health.23,27 
Instructor-led light exercise: Classes led by exercise physiologists meeting at the same 
length and frequency as the Qigong group with focus on light resistance training, 
stretching, and a light aerobic component.  
Pittsburg Sleep Quality Index (PSQI): a self-rated questionnaire that assesses sleep 
quality and disturbance through nineteen individual items that generate a global score and 
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CHAPTER 2: REVIEW OF THE LITERATURE  
2.1 INTRODUCTION  
 A search of relevant medical literature was conducted between August 2019 and 
June 2020 using Ovid Medline, EMBASE, PsychINFO, AMED, Cochrane, and Scopus. 
Primary searches were performed using the combination of MeSH terms “breast 
neoplasms,” “cancer survivors,” “Qigong,” “medicine, Chinese traditional,” “sleep,” and 
“sleep initiation and maintenance disorders.” Additional search terms included Tai Chi, 
Tai Ji, mind-body therapies, mind-body intervention, exercise therapy, survivors, cancer 
survivors, neoplasms, Fitbit, accelerometry, quality of life, insomnia, and sleep-wake 
disorders. The search was limited to articles written in English and to those with human 
subjects. Articles were analyzed for relevance to the topic and clinical trials, systemic 
reviews, and meta-analyses were prioritized. Additional references were extracted from 
reference lists of primary articles if found to be pertinent to our study. The literature 
search and review demonstrate the prevalence of sleep disturbance in breast cancer 
patients undergoing treatment and the prevalence of symptoms that persist following 
treatment. It is evident through the search that many alternative therapies have been 
considered and studied for this issue, but there remains much to learn regarding Qigong 
and its efficacy in our population.  
2.2 REVIEW OF EMPIRICAL STUDIES 
2.2.1 Sleep Disturbance in Female Breast Cancer Survivors 
Multiple studies have demonstrated the prevalence of sleep disturbance in female 
breast cancer patients both during and after treatment. One study investigated subjective 
sleep disturbance in women with breast cancer stages I-III undergoing four rounds of 
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chemotherapy compared to age-matched women without cancer.1 They found that 
women with breast cancer experienced worse subjective sleep quality as measured by the 
PSQI than their non-cancer counterparts (p=0.011 at start of treatment T1, p<0.001 after 
four cycles of chemotherapy T2, and p=0.02 one year after treatment initiation T3).1 
Similarly, an observational study of women with stages I-IIIA breast cancer found that 
between six months and 12 months after the start of endocrine therapy, self-reported 
sleep quality with the PSQI went from poor (a score of 6-10) to very poor (a score of 
≥10) (p=0.03).2 A third study found that breast cancer patients receiving cancer treatment 
tended to report worse sleep (p<0.06) and experience longer sleep latency (p<0.10) than 
those not receiving treatment.3 They also found that sleep disturbance was correlated with 
reported deficits in quality of life including decreased ability to perform daily tasks and 
feelings of low energy.3 These studies demonstrate that women experience sleep 
disturbance both before the start of treatment and throughout the course of treatment. 
A few studies have demonstrated that sleep disturbance can extend beyond the 
completion of cancer treatment and can persist for years. One survey found that women 
can experience it an average of 4.2 years after completion of treatment.4 A cross-sectional 
study investigated sleep-wake disturbance in BCS who were a mean of 5.6 years after 
completion of cancer treatment and age-matched them to women without breast cancer.5 
Sleep disturbance was found to be more common and more severe in the BCS. Mean 
global PSQI scores were significantly different between groups (p<0.01), and the PSQI 
sub-categories of sleep quality, sleep latency, sleep duration, number of disturbances, and 
daytime dysfunction were all found to be significantly worse (p<0.05 for all variables) in 
women with breast cancer.5 A strength of this study was that it included a sample of 
13 
 
African American BCS, adding to the diversity and generalizability of results. 
Limitations include the fact that the percentage of women on endocrine therapy in the 
sample was low, so it may not be representative of all BCS. Further, there could be a 
source of selection bias as women were recruited to a “quality of life study” and this may 
attract women who are already seeking improvement in their sleep disturbance.5  
2.2.2 Interventions for Sleep Disturbance in Breast Cancer Survivors 
Treatment for sleep disturbance in BCS is primarily focused on the use of either 
pharmaceutical interventions or CBT-I. The choice of medication is usually from one of the 
following classes: non-benzodiazepine hypnotics, benzodiazepines, or sedative 
antidepressants.6 All three classes have shown to be beneficial for sleep in cancer patients; 
however, they each contain a side effect profile and the first two classes have habit-forming 
and addiction potential, respectively.6 Additional pharmaceutical treatments include 
melatonin, some types of antipsychotic medications, anticonvulsants, and valerian root.6 
These medications have proven beneficial for sleep disturbance for BCS in the short term, 
but they are not meant to be used for chronic insomnia. Additionally, side effects can further 
complicate comorbidities. 6  
CBT-I is a form of psychotherapy that uses the techniques of stimulus control 
behaviors and sleep restriction to help a patient learn how to better sleep.7 It is the gold-
standard treatment for insomnia as recommended by the American Academy of Sleep 
Medicine.7 It has shown to be effective for insomnia in cancer survivors and, unlike 
medications, has effects that last after cessation of treatment.6 Though benefits exist, 
successful treatment with CBT-I is often dependent on access to clinicians, insurance 
coverage of sessions, and a patient’s willingness to attend sessions.7,8 Often clinicians lack 
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knowledge of effective treatment options for insomnia like CBT-I and there is a shortage of 
providers with adequate training in the intervention.8 Yet, sleep disturbance continues to be 
a major concern for BCS with many reporting their symptoms going untreated.9 There is a 
need to offer more treatment options for sleep disturbance in this population. 
After CBT-I, exercise is a primary non-pharmaceutical intervention recommended 
for sleep disturbance and multiple studies have demonstrated its benefits.6 A meta-analysis 
of 33 RCTs demonstrated that exercise had benefits on mental health, emotional and social 
well-being, and depression and anxiety in BCS.10 One study randomized postmenopausal 
BCS to either a 3-month exercise intervention or a control group and they found the 
intervention group to have significant improvements in PSQI-rated sleep duration 
(p=0.03).11 This study had some limitations including small sample size, the inclusion of 
only women who had completed primary treatment, and only women with ductal carcinoma 
in situ or stage I-II breast cancer.11 In a second study, a 3-month long exercise intervention 
based on physical activity recommendations by the American Cancer Society was found to 
significantly improve PSQI global sleep quality scores compared to a usual care intervention 
(mean between-group difference= -1.4; 95% CI=-2.1 to -0.7; p<0.001) in BCS.12 The results 
remained significant at a 6-month follow up as well (mean between-group difference=-1.0; 
95% CI=-1.7 to -0.1; p=0.01).12 This study lacked generalizability as underrepresented racial 
and ethnic groups represented only a fraction of the study participants. However, a large 
sample size, strict randomization, and higher retention rates presented strengths that give the 
results more validity.12  
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2.2.3 The Benefits of Qigong 
The benefits of Qigong extend to multiple aspects of health and well-being. This 
association has been studied in both the general population and in cancer patients. For the 
purpose of this literature review, we will include some studies that combined Tai Chi 
with Qigong or used gentler forms of Tai Chi. A review of the health benefits of Qigong 
and Tai Chi in the general population including healthy elderly individuals and those with 
chronic disease found benefits on the cardiorespiratory systems, physical function, 
balance and falls prevention, bone health, and patient-reported symptoms including 
quality of life, mood, and fatigue.13 One study investigated the effects of Qigong exercise 
in community-dwelling older adults with a mean age of 74.8 after a twice-weekly Qigong 
exercise session for eight weeks.14 Results showed statistically significant improvement 
in physical ability (p<0.001), functional health (p=0.001), balance (p<0.001), functional 
reach (p<0.001), depression (p=0.005), and spiritual well-being (p=0.004).14 The study 
also reported good adherence to the Qigong regimen with approximately 94% of 
participants performing Qigong at least once a week outside of sessions.14 Participants 
reported that the benefits they received from the practice gave them more incentive to 
continue with it. The study further demonstrated the physical benefits of Qigong to be 
comparable to that of aerobic exercise as there was a significant mean change in the six-
minute walk test (6MWT). It should be noted that there was no control group in this 
study which brings forth a possible limitation of extension of these results and 
conclusions should be more conservative.14  
 In addition to Qigong being studied in the general population, it has also been 
studied in patients with various forms of cancer. One study compared Medical Qigong to 
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a usual care group in patients with breast, lung, prostate, and colorectal cancers.15 The 
Medical Qigong group had significant improvement in overall quality of life (p<0.001), 
fatigue (p<0.001), mood disturbance (p=0.021), and inflammation as measured by C-
reactive protein (CRP) (p<0.044).16 It must be noted that this study did not explicitly 
define the usual care group making it difficult to interpret and apply the results of this 
study. Still, a similar study also reported that Medical Qigong improved inflammation 
and cognitive function.17 Finally, a third study on patients with advanced-stage non-small 
cell lung cancer and those with gastrointestinal cancer found that Medical Qigong 
appeared to have equivalent effects as standard endurance and strength training on 
anxiety, depression, and quality of life.18  
Three studies have demonstrated the benefits of Qigong, or a combination of 
Qigong/Tai Chi, on sleep in patients with cancers other than breast cancer. In patients 
with non-Hodgkin’s lymphoma undergoing chemotherapy, there was a statistically 
significant improvement in sleep quality over time from pre-test to post-test (p<0.001) 
after 21 days of a Qigong intervention.19 When Qigong/Tai Chi was compared to exercise 
and a waitlist control in a population of prostate cancer patients during radiation therapy, 
sleep duration of participants in the Qigong/Tai Chi group was significantly longer than 
that of the exercise group (p=0.047); there was also a trend for longer sleep duration in 
the Qigong/ Tai Chi group compared to the waitlist control group (p=0.07).20 However, 
the difference was no longer significant at the end of radiotherapy or at follow up time 
points. It must be noted that this study was limited by a small sample size.20 Another 
study explored sleep disturbance in survivors of nasopharyngeal cancer by comparing a 
6-month Qigong/Tai Chi intervention to a control group receiving no therapy.21 Sleep 
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disturbance, measured with the Medical Outcomes Study Sleep Scale (MOS), statistically 
decreased in the Qigong/Tai Chi group (p<0.006) between mid-intervention and follow 
up, indicating that the results were durable.21 A limitation of this study was a lack of 
randomization of group allocation, presenting possible selection bias, as well as a high 
total attrition rate, though an intention-to-treat analysis was used.21  
Qigong has been studied regarding its effect on the health and well-being of 
women with breast cancer. One study conducted in Malaysia investigated quality of life 
with the FACT-B in BCS participating in either a Qigong exercise group, a standard 
exercise program group, or a usual care group.22 The Qigong group’s mean FACT-B 
scores at the end of the 8-week intervention period were 7.1 units higher (95% CI=0.36-
13.9) than the exercise group, and 6.7 units higher (95% CI=0.04-13.3) than the usual 
care group.22 Similarly, an RCT conducted in Thailand in 2015 investigated the effects of 
a Qigong/Tai Chi program on self-esteem, fatigue, cortisol, and quality of life in women 
with breast cancer.23 Participants were assigned to either a 4-week Qigong program or 
exercise intervention. Outcome measures included self-esteem as measured by the 
Rosenberg Self-Esteem Scale (RSE), fatigue as measured by the Fatigue Symptom 
Inventory (FSI), quality of life as measured by the FACT-B, and stress measured with 
cortisol samples.23 Mean scores across 12 weeks significantly changed only in the 
Qigong group (p<0.05 for all four outcomes) and remained significant after controlling 
for baseline scores.23  
The generalizability of these studies is limited by the fact that both were 
performed in Asian countries and had small sample sizes.22,23 People in Asian countries 
are more familiar with the practice of Qigong compared to people living in the United 
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States, so prior knowledge of the practice and its benefits could have presented sources of 
information bias to participants in these studies.22,23 Nevertheless, findings from these 
studies as well as others have demonstrated Qigong to be a safe and beneficial CM 
treatment for BCS.22-24  
2.2.4 Qigong as an Intervention for Sleep Disturbance in Female Breast Cancer 
Survivors 
Four studies to date have investigated the use of Qigong as an intervention for 
sleep disturbance in BCS. The first was an RCT conducted in Shanghai, China in 2013 
looking at the effect of Qigong practice on quality of life outcomes including depressive 
symptoms, fatigue, sleep disturbance, overall quality of life, and stress in women with 
breast cancer undergoing radiotherapy.25 Women with stage 0-III breast cancer were 
randomized to a Qigong intervention or waitlist control. Women in the Qigong 
intervention attended five, 40-minute Qigong classes throughout a 5-6-week period and 
were given additional materials to encourage practice on their own on non-meeting days. 
All participants completed the Center for Epidemiologic Studies Depression Scale (CES-
D) to assess depression, the Brief Fatigue Inventory (BFI) to assess fatigue, the PSQI to 
assess sleep disturbance, and the Functional Assessment of Cancer Therapy- General 
(FACT-G) to assess overall quality of life. Stress was measured by salivary cortisol. Data 
were collected at baseline (T1), during the middle of radiation therapy (T2), during the 
last week of radiation therapy (T3), and 1 month (T4) and 3 months (T5) after the 
completion of radiation therapy. To evaluate the effectiveness of the intervention, the 
group by time interaction was investigated and they compared least squared means for 
19 
 
each group at each time point while controlling for baseline levels of each outcome 
variable.25 
Multilevel modeling analysis revealed a significant main effect of depression 
scores decreasing over time (F (4,367)=10.91, p=0.001) indicating that depression scores 
decreased in the Qigong group but not in the waitlist control group.25 There were no 
significant group differences for fatigue, sleep disturbance, overall quality of life, or 
cortisol rhythms. When baseline symptoms of depression were controlled for, there were 
statistically significantly lower depressive symptoms (F (4,368)=3.98; p=0.004), fatigue 
(F (3,275)= 4.25; p=0.01), and overall quality of life scores (F (3,275)=3.03; p=0.02) in 
the Qigong group versus the waitlist control group.25 Although the results of this study 
did not demonstrate the benefits of Qigong on sleep, it was demonstrated that Qigong can 
benefit quality of life in women with breast cancer undergoing radiotherapy, and that the 
benefits can potentially extend beyond treatment completion. Further, this study 
demonstrated Qigong to be a safe therapy for patients in active treatment and adherence 
was high, with 65% of participants adhering to at least 80% of the Qigong classes.25  
There were limitations to this study that could potentially explain the lack of 
effect of the intervention on sleep. First, there was no active control group.25 It cannot be 
ruled out that the effects of the intervention were due to social support at classes, a 
scheduled routine, or the attention participants gave to the intervention, as opposed to the 
waitlist control group that had no guidance or regimen. The sample was limited to 
Chinese women in one site in Shanghai, China. Though women with prior practice of 
Qigong were excluded from the study, it cannot be ruled out that participants may have 
had prior knowledge of Qigong and its benefits with it being of Eastern medicine origin. 
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This brings forth a possible source of information bias on the part of the participants. 
Furthermore, this limited sample inhibits the generalizability of results to the whole of the 
breast cancer population. It is not clear whether all participants in the sample had 
completed or were undergoing chemotherapy or endocrine therapy.25 Therefore, it is 
possible this sample experienced sleep disturbance to different degrees than a sample 
would have that had all undergone some form of chemotherapy. It must be recognized 
that breast cancer patients undergoing treatment have been found to be more likely to 
experience sleep disturbance than those not undergoing treatment, and treatment effects 
can extend beyond the completion of therapy.3,4 Finally, follow up at three months after 
completion of radiation therapy may not have been long enough to see the benefits of 
Qigong on sleep. Therefore, studies with longer follow up after completion of therapy are 
needed.  
The second study to look at the association was a double-blinded RCT 
investigating the effects of a combined Qigong/Tai Chi Easy (QC/TCE) intervention on 
fatigue, depression, and sleep disturbance in BCS.26 Their aim was to test the effect of the 
meditative movement component of QC/TCE so the physical activity component was 
kept constant by comparing the intervention to a placebo “sham Qigong” (SQG). The 
SQG intervention used similar moves as the QC/TCE intervention but removed the 
emphasis on breathing and meditation. The interventions were both one-hour-long 
sessions meeting twice per week for 12 weeks and participants were blinded and 
randomized to the interventions. Eighty-seven postmenopausal women diagnosed with 
stages 0-III breast cancer who were 6 months to 5 years past primary treatment including 
surgery, radiation, or chemotherapy and reporting clinically significant fatigue were 
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enrolled in the study. Outcomes of the study included fatigue as measured by the FSI, 
sleep disturbance as measured by the PSQI, and depression as measured by the Beck 
Depression Inventory (BDI); outcomes were measured at baseline, post-intervention, and 
at 3 months follow up. Hierarchical linear models were used to assess independent effects 
of the interventions and time, and a likelihood ratio test was used to assess the interaction 
between time and intervention.26  
There was a statistically significant decrease in fatigue in the QC/TCE group at 
both the post-intervention timepoint (p=0.005) and at the 3-month follow up time point 
(p=0.024).26 There was also a statistically significant interaction between the 
interventions and time for fatigue (p=0.0116). There was no statistically significant 
interaction between the two groups across time for either depression (p=0.94) or sleep 
disturbance (p=0.27). However, in both the QC/TCE and SQG groups individually there 
were statistically significant decreases across time for both depression and sleep 
disturbance (both p<0.05). These results demonstrated that the QC/TCE group was 
superior to the SQG group for BCS experiencing fatigue over time. They also 
demonstrated that both the QC/TCE intervention and the SQG intervention improved 
participants’ depression and sleep disturbance over time, independently.26  
A strength of this study is that the “placebo” design helped control for any 
differences between groups in terms of attention, focus, or social aspects of being in a 
class, which other studies have lacked.26 It allowed the investigators to analyze the 
meditative and breathing component of Qigong practice independent of the physical 
movement component. There were a few limitations to this study with the first being the 
possibility that the intervention and control group were not different enough and thus 
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lacked a strong enough comparison to see the benefits of one over the other. Furthermore, 
intention-to-treat analysis was not utilized which could have biased results by not 
accounting for dropouts. In this study, the QC/TCE intervention was specifically 
designed to achieve effects for fatigue which could have altered the results with a lack of 
focus on the other two outcomes, depression and sleep disturbance. Despite the lack of 
significance of between-group interaction on sleep, it is apparent that low-intensity 
physical activity, in general, is beneficial for sleep disturbance as both interventions 
incorporated this and demonstrated effects over time.26 There is a need for a comparison 
group matched for exertion, dose, and frequency to a Qigong group, but with still enough 
contrast to elucidate its benefits.  
The third study was a single-arm pilot study investigating the benefits of Qigong 
exercise on sleep disturbance, fatigue, and quality of life in BCS.9 Participants included 
eight women diagnosed with stages I-III breast cancer and an average of 46.4 months 
from completion of primary cancer treatment including surgery, radiation therapy, or 
chemotherapy and all with a concern for sleep disturbance or fatigue. The subjects 
underwent two Qigong training sessions and then one group session per week for six 
weeks. In addition, they were instructed to complete exercises at home twice per day 
every day. Participants completed assessments at baseline and after the six-week 
intervention including the PSQI for sleep, the Multidimensional Fatigue Inventory (MFI-
20) for fatigue, and the MOS short-form 36 (SF-36) for quality of life. A multivariate 
analysis of variance (MANOVA) was performed to look for differences in means 
between the outcomes. A MANOVA was also used to analyze significance in each of the 
seven subcategories of the PSQI and the eight subcategories of SF-36.9  
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There was a significant improvement in global PSQI scores (p<0.01); the mean 
score went from 10.3 (SD 3.6) at baseline to 5.4 (SD 2.3) at the end of the study.9 There 
was also a significant improvement in the two PSQI subscales of sleep quality and 
daytime dysfunction (p<0.007) with the rest of the subscales demonstrating non-
significance. There were also significant changes in MFI-20 (p<0.01) and SF-36 (p<0.01) 
scores indicating improvements in both fatigue and quality of life in the population by the 
end of the intervention. The “role limitations due to physical health” subcategory of the 
SF-36 was significant (p<0.006) but all other subcategories were not significant.9  
This study demonstrated that Qigong exercise can improve sleep and quality of 
life in BCS experiencing sleep difficulties.9 It also found a correlation between sleep 
disturbance and fatigue as both improved after the intervention. Limitations of the study 
include the fact that the study was a pilot feasibility trial without a control group, the 
sample size was small, and study participants were not blinded to the intervention.9 Based 
on the limitations across these studies, there remains a need for an active control 
comparison group to fully investigate the effectiveness of Qigong.  
The final study explored whether Tai Chi Chih (TCC), a slower and more gentle 
form of Tai Chi, was noninferior to CBT-I in BCS with diagnosed insomnia.7 Study 
participants included ninety female BCS who fulfilled criteria for insomnia in the 
Diagnostic and Statistical Manual Fourth Edition (DSM-IV) and the International 
Classification of Sleep Disorders, and who reported sleep difficulties greater than or 
equal to three times per week for greater than three months, and had completed treatment 
at least six months prior to the start of the study. Participants were randomly assigned to 
either TCC or CBT-I. The TCC intervention participated in one, 2-hour long group 
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session per week for three months that focused on movement meditation with an 
emphasis on control over physical function. The CBT-I intervention followed the same 
time, frequency, and length as the TCC intervention and was also delivered in a group 
format. Both groups participated in assessments at baseline, 2 months, 3 months, 6 
months, and 15 months after the start of intervention. One assessment was the PSQI to 
measure insomnia treatment response, with the primary outcome being treatment 
response at month 15; behavior outcomes were also assessed using the FSI for fatigue, 
the Epworth Sleepiness Scale for sleepiness, and the Inventory of Depressive Symptoms 
for clinician-rated depressive symptoms.  Participants also completed daily diaries using 
the Pittsburg Sleep Diary. Method of analysis was noninferiority using an F statistic from 
linear mixed models for the primary outcome, and Fisher’s exact test for secondary 
outcomes.7  
Results demonstrated noninferiority of TCC to CBT-I at the primary outcome 
endpoint of month 15 (p=0.02), as well as at month 3 (p=0.02), and month 6 (p<0.01).7 
Mean PSQI scores at month 15 were less than the threshold for clinical sleep disturbance 
in both groups, demonstrating overall treatment effects (p<0.001). There were non-
significant between-group differences (p>0.4) in total sleep time and wake after sleep 
onset from sleep diary data. For secondary outcomes, there were improvements in both 
groups on fatigue severity, daytime sleepiness, and depression (p<0.001), but between-
group differences in the three categories were non-significant (p>0.5).7  
 This study demonstrated TCC to be noninferior to CBT-I on BCS with clinical 
insomnia.7 The benefits were found to persist after one year of follow up in both groups. 
Treatment exposure in the two groups were matched on time, frequency, and length. 
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Participants were blinded to the treatment protocol which helped to reduce information 
bias. The sample was somewhat limited with the majority of women being white and 
well-educated, limiting the generalizability of results. Another limitation to this trial was 
low adherence to TCC practice outside of sessions; yet because the two interventions 
were exposure matched, this did not appear to affect noninferiority results.7 Although 
TCC and Qigong differ, results from this study can be extended to the use of Qigong in 
our study as the foundation of both TCC and Qigong is that of meditative movement with 
a gentler foundation than that of traditional Tai Chi.  
2.3 REVIEW OF RELEVANT METHODOLOGY 
 The following section is a review of methodology that is relevant to the proposed 
study. A more detailed explanation of the proposed study methods is discussed in Chapter 
3.  
2.3.1 Study Design  
 The proposed study will be a two-arm, single-blinded RCT examining the benefits 
of a biweekly Qigong class compared to a biweekly light exercise class for 12 weeks on 
sleep disturbance and quality of life in female BCS. The study will recruit from two 
hospitals in the Yale New Haven Health system in New Haven, CT as well as private 
oncology practices and support groups. The study will be conducted at community 
centers in the New Haven, CT area.  
 The choice of an RCT as the study design stems from a lack of previously 
conducted RCTs comparing Qigong with an active control with the primary outcome of 
sleep disturbance in BCS. As discussed previously, only three studies have utilized an 
RCT design to investigate Qigong or Qigong/Tai Chi on sleep in breast cancer patients or 
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survivors.7,25,26 These studies lacked generalizability with small sample sizes and limited, 
non-representative populations. Additionally, one study compared Qigong to a “sham 
Qigong” that potentially did not offer enough contrast as a control to the Qigong 
intervention itself.26 No previous study directly compared Qigong to dose- and 
frequency-matched active exercise. A pilot pre-, post-intervention single-arm study 
showed benefits of Qigong on sleep in BCS; however, the single-arm nature of this study 
without a comparison group limited validity of results.9 Despite this lack of robust RCTs, 
other CM studies have utilized the RCT design including those comparing Qigong to 
exercise on patients with prostate cancer and non-Hodgkin lymphoma, as well as a study 
comparing Iyengar yoga to regimented exercise in female breast cancer patients.19,20,27 
These studies allowed for the elimination of possible bias and confounders within the 
sample population by randomizing participants and standardizing a comparison 
group.19,20,27 For these reasons our study will follow the same design. 
 The proposed study will recruit participants from multiple sites to improve upon 
the small sample sizes and limited variation in populations of previous studies. We hope 
to extend the generalizability of our results and recruit a representative and larger sample 
population by recruiting from multiple sites. Recruitment in the proposed study is based 
on a study in which participants were recruited via two hospital state tumor registries in 
Connecticut with supplementation of referrals from both providers and self-referrals.28 
We will also recruit from Sisters’ Journey, a support group for African American women 
with breast cancer or a history of breast cancer in New Haven, CT. We hope to increase 
the heterogenicity of our sample population and the generalizability of results by 
including this site in our recruitment process.  
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2.3.2 Selection Criteria 
 A complete list of inclusion and exclusion criteria can be found in Chapter 3. 
Selection criteria are based on previous studies of similar populations.9,26 Participants will 
be considered for our study if they are at least 18 years old, have been diagnosed with 
stages 0-III breast cancer, are six months to five years past completion of primary 
treatment for breast cancer (surgery, radiation, chemotherapy, or endocrine therapy), and 
show no evidence of cancer recurrence. Unlike previous studies that have either not 
required an insomnia diagnosis or strictly required an insomnia diagnosis for enrollment, 
we will enroll participants who score greater than a five on Global Sleep Quality on the 
PSQI. This is the threshold between which self-reported good and poor sleepers are 
distinguished.29 Assessments will be administered upon enrollment with baseline 
assessment data. We will exclude women who have a diagnosis of a concurrent medical 
condition likely to influence short-term survival, a history of a major psychiatric illness 
requiring hospitalization including severe sleep-wake disorders, and current alcohol or 
drug dependence.30 Exclusion of these factors will help preclude the possibility of results 
being attributed to other conditions rather than our intervention. The current use of sleep 
medication will not be part of the exclusion criteria. There is a sub-score on the PSQI that 
accounts for sleep-medication use, and randomization to intervention should account for 
any baseline differences between groups.  
We will exclude women who have prior experience with Qigong and/or Tai Chi. 
This choice is consistent with one study that excluded women who had previous 
experience with Qigong or Tai Chi, but only within the past year.25 This was especially 
important in the study as these practices are extremely well known in China where the 
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study was conducted. Another referenced study excluded those who had practiced 
Qigong or Tai Chi within the past year, as well as patients with physical disabilities 
including an inability to walk unassisted, chronic pain while walking, or difficulty 
walking for 20 mins.20 We will follow suit regarding physical ability as both of our 
treatment groups require baseline abilities in order to perform the movements.  
2.3.3 Potential Confounding Variables 
 Confounding variables can threaten the validity of the results of a study. Like 
previous studies, variables to be considered in this study include age, race, comorbidities, 
cancer stage, cancer treatment, treatment with endocrine therapy, time since diagnosis, 
menopausal state, baseline sleep quality, body mass index (BMI), and baseline level of 
physical activity.12,26 These are consistent with previous studies that have looked at 
Qigong or exercise on sleep in BCS.12,26 We will explore some of these variables in this 
review. 
Studies are mixed regarding what age range experiences the most sleep 
disturbance in BCS. One reported that younger women may have a worse disease burden 
than their elder counterparts considering they will more likely be dealing with concurrent 
career and childcare concerns.4 They also reported an association between younger age 
and both increased disease severity and increased sleep disturbance.4 However, other 
studies have demonstrated that sleep disturbance may be worse for women who are post-
menopausal and of older age.31 Age is also associated with different physical abilities.32 
For these reasons, age will be controlled for in our study. We will include all women 
greater than age 18 in our study who meet the other inclusion criteria, and we will control 
for age differences with randomization to intervention.  
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Menopausal state, whether pre- or post-menopausal, endocrine symptoms, and 
treatment with endocrine therapy can all affect sleep disturbance in BCS.33 Sleep 
disturbance is common in menopausal women independent of whether they are a BCS or 
a healthy woman.33 Treatment with endocrine therapy can affect sleep disturbance as well 
as physical ability.34 Aromatase inhibitors (AI), a type of endocrine therapy, have been 
associated with both insomnia and arthralgias.34 In this study we will control for baseline 
menopausal symptoms by administering the Functional Assessment of Cancer Therapy- 
Endocrine Symptoms (FACT-ES) at baseline to control for differences between groups. 
To control for differences in menopausal status and treatment with endocrine therapy we 
will use self-report at enrollment. 
Body mass index (BMI) and baseline physical activity are other possible 
confounders to be considered in our study. High BMI and obesity are prevalent in BCS 
and predictive of worse overall survival than normal BMI.31,35 Additionally, obesity is 
associated with sleep conditions such as sleep apnea and increased daytime sleepiness.31 
Breast cancer treatment has been found to cause decreased physical activity both during 
and after treatment which can further contribute to sleep difficulties.5 Again, 
randomization of our sample to each intervention will attempt to control for differences 
in our population in regards to these factors. We will administer the International 
Physical Activity Questionnaire (IPAQ) at baseline to further account for any differences 
between groups.  
2.3.4 Randomization and Blinding Technique  
 Randomization of participants to intervention will be based on two studies that 
investigated CM interventions on sleep in cancer survivors.7,36 Both of these RCTs used a 
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computerized random number generator and a 1:1 allocation to the intervention and 
control groups. Randomization in this way allowed for baseline characteristics to be 
controlled for and reduced the possibility of bias from confounding variables. The 
proposed study will follow the same guidelines for the allocation process.  
 Blinding of the proposed study will follow suit with a study that used a partial 
blinding protocol in which participants were blind to the hypothesis as well as the content 
of the other treatment group.7 Due to the nature of the intervention, participants cannot be 
blinded to their specific interventions. However, this method of partial blinding should 
allow for reduced information bias. In accordance with the same study, investigators and 
outcome assessors will be blinded to subject allocation at baseline and at assessment 
points thus creating a single-blinded trial.7 
2.3.5 Intervention   
The Qigong intervention will follow the framework used by three studies.14,20,37 
The outcomes for our study will be based on the Layers Model created by Yang et al., 
and the framework of our intervention will follow this study in combination with another 
study that also based their intervention on the Layers Model.14,37 The first study created a 
Qigong exercise regimen comprised of seven movements; a sequence that was short and 
easy to remember but incorporated a wide range of motion for the entire body.37 Their 
study centered on the need for the intervention to be accessible to nearly any level of 
physical ability and experience.37 The second study employed a “Health Qigong” 
program based on gentle bodily movements, breathing exercises, and meditation taught 
and led by a Qigong practitioner and conducted in groups of 10-15 people to traditional 
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music.14 Unlike the first study whose intervention was three times per week for 24 weeks, 
we will follow suit with a third study in implementing a 12-week-long, biweekly 
intervention.20 This will attempt to ensure participant adherence to the intervention and to 
avoid loss to follow up.  
Instructors for the intervention will be trained under the accreditation standard 
guidelines for Tai Chi and Qigong by the Medical Tai Chi and Qigong Association 
(MTQA).38 The guidelines were developed by health professionals, integrative medicine 
academics, Tai Chi and Qigong master instructors, and public safety officers from 
countries including USA, China, Canada, Korea, and several countries in Europe.38  
 The light exercise comparison group will be based on the light exercise program 
that a referenced study implemented who compared Qigong to light exercise on sleep in 
survivors of prostate cancer.20 Their light exercise program was led by an exercise 
physiologist and consisted of light resistance training and stretching, with the level of 
exertion and movement matching that of their Qigong intervention. As these researchers 
did, we will implement an active control in our study with light exercise matched on 
dose, frequency, and length to our Qigong intervention.   
2.3.6 Primary and Secondary Outcome Measures 
The Layers model is to be used as the basis for the outcomes in our study. It was 
developed by Yang et al. when they investigated the subjective experiences of 
Qigong/Tai Chi in older adults after a six-month intervention using semi-structured 
interviews.37 The model is based on the idea that Qigong/Tai Chi affects participants in 
five overlapping dimensions: physical, mental, emotional, social, and spiritual. As 
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participants go deeper and longer into their practice, they transition from experiencing 
benefits in a single dimension (Layer 1) to experiencing complex integration of four 
and/or five dimensions (Layer 4).37 Limitations of the study include small sample size, a 
purposeful selection process, and subjective data as results, bringing about considerations 
for both selection bias and information bias.37 Still, the Layers Models presents a strong 
foundation to investigate our outcomes in this study. On this basis, our outcomes will be 
sleep disturbance as measured by the PSQI, objective sleep parameters as measured by a 
Fitbit Alta HR, and quality of life in the four other dimensions as measured by the FACT-
B and the FACIT-sp.  
The primary outcome of this study is subjective sleep disturbance as measured by 
the PSQI. The PSQI is a 19-item self-report questionnaire that assesses sleep quality and 
quantity.29 The Global Sleep Quality scale is an overall sleep quality score that uses the 
19 items to assess global sleep quality with higher scores indicating worse sleep quality.29 
It has a reliability coefficient, or Cronbach’s alpha, of 0.83 in the general population.29 
There is evidence supporting the internal consistency of the PSQI in cancer patients. Data 
from two studies on the Global Sleep Quality scale from the PSQI in cancer patients 
yielded Cronbach’s alphas of 0.81 and 0.77, demonstrating this tool as reliable in the 
assessment of sleep in cancer patients.29 A score of greater than 5 on Global Sleep 
Quality distinguishes between good and poor sleepers and has a diagnostic sensitivity of 
89.6% and specificity of 86.5%.29 The questionnaire also yields 7 component subscales: 
subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbances, use of sleep medication, and daytime dysfunction.29 
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One secondary outcome will be objective measures of sleep patterns recorded by 
a Fitbit Alta HR. Adding an objective measure of sleep will help reduce sources of 
response bias from the self-report PSQI. Polysomnography (PSG) is the gold standard 
objective measurement for the diagnosis of sleep disorders but there remain a few 
disadvantages.39 The environment in which it is conducted can be uncomfortable, 
anxiety-provoking, and can interfere with sleep.39 It is also expensive, requires trained 
technicians, and formal sleep facilities, yet less than 50% of sleep studies in recent years 
have been conducted in formal sleep facilities.39 Wristband actigraphy is another 
objective measure of sleep widely used in sleep studies that senses accelerated motion.39 
However, this technology is also expensive with watches and software ranging from 
$1225 to $1850 a piece.40 It has been found to overestimate sleep time and has a low 
sensitivity for detecting wake after sleep onset time (WASO).39 Instead, this study will 
measure objective sleep patterns using the Fitbit Alta HR, a wearable wrist device that 
can measure both daytime activity and sleep.39 It is easy to use, already widely used by 
many consumers, and inexpensive at about $100 per device.40  
 The Fitbit Alta HR uses body movement, heart rate, and heart rate variability 
(HRV) to assess multiple parameters of sleep.39 In this study, the primary outcomes to be 
observed by use of the Fitbit will be total sleep time (TST) measured in minutes, sleep 
efficiency (SE) measured as a percentage, wake after sleep onset (WASO) measured in 
minutes, and sleep onset latency (SOL) measured in minutes; these outcomes correlate 
most with the subscales of the PSQI. The Fitbit Alta HR is a newer-generation Fitbit 
model and in a systemic review was found to better estimate TST, SE, and WASO than 
early-generation models.39 In comparison to PSG, there was a lack of statistically 
34 
 
significant difference in values of WASO (p=0.92), TST (p=0.29), and SE (p=0.19), as 
well as only small differences in SOL (0.03).39 The Fitbit Alta HR was also found to have 
higher sensitivity (0.95-0.96) and specificity (0.58-0.69) in detecting sleep epochs than 
earlier-model Fitbits and actigraphy.39  
Other secondary outcomes in this study will be the four other dimensions of 
quality of life affected by Qigong: mental, emotional, social, and spiritual. We will assess 
these using the FACT-B and the FACIT-Sp. The FACT-B is a 44-item self-rated 
questionnaire that is composed of the FACT-G plus a 9-item subscale specific to quality 
of life in those with breast cancer.41 The FACT-G component of the FACT-B is a 
multidimensional tool with five subscales including Physical Well-Being (PWB), 
Emotional Well-Being (EWB), Social Well-Being (SWB), Functional Well-Being 
(FWB), and Relationship with Doctor (RWD).41 The reliability coefficient for the FACT-
G subscales are noted to be >0.80, but only around 0.63 for the breast cancer subscale, 
the FACT-B.41 However, it has been noted that the breast cancer subscale has expected 
correlations with other measures of quality of life in this population and may be low due 
to items being specific to breast cancer patients.41 The FACIT-Sp is a 12-item subscale of 
the FACT-G and is used to assess spirituality specifically for those with chronic and/or 
life-threatening illnesses.42 It has a Cronbach’s alpha reliability coefficient 0.87.42 
2.3.7 Sample Size and Statistical Significance   
 Previous data from studies using both Qigong and exercise and the PSQI will be 
used to calculate sample size for this study. One study found a mean change of 1.3 
points (SD 3.2) on the PSQI at 3 months after an aerobic and strength-based 
intervention in BCS, an intervention close to that of the comparison group in our 
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proposed study.11 Two other studies found similar mean changes at 1.4 units and 1.49 
units; however, one study had a more frequent and vigorous exercise regimen than our 
proposed study, and the other was in endometrial cancer survivors, respectively.12,43 For 
these reasons, 1.3 was chosen as this study’s expected mean change for the comparison 
group. A study found a mean change of 4.9 (SD 3.6) difference in the PSQI after a 12-
week Qigong intervention and this study most closely follows the same length, 
intervention type, and study population as our proposed study.44 Taking these studies 
into account we aim to detect an effect size of 3.6 units on the PSQI with a standard 
deviation of 3.6. Analysis of previous clinical trials using Qigong has demonstrated 
dropout rates between 2-10%; we will conservatively use 10% as an estimate of 
dropout rate in our study.25,26 Statistical analysis will follow that of a study that used a 
multiple time by interaction model.26 Considering multiple comparisons, an alpha of 
0.01 with a Bonferroni adjustment for multiple comparisons between groups will be 
used with 90% power. Accounting for a 10% dropout rate, a sample size of 36 
participants per group, or 72 participants total will need to be recruited for the proposed 
study (Appendix C).  
2.4 CONCLUSION   
 This literature review presents studies demonstrating the problem of sleep 
disturbance in BCS and its impact on quality of life. There is evidence supporting 
different avenues for both pharmacological and non-pharmacological treatment, though 
the literature reports that women are seeking more forms of CM treatment for their sleep 
disturbance. Qigong is one CM option that has been tested as a means for treating sleep 
disturbance in BCS and has demonstrated improvements, yet few robust studies exist 
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demonstrating its efficacy. Studies have lacked generalizability with small sample sizes 
and restricted sample population characteristics. They have also lacked active controls 
with an exercise comparison matched for dose, frequency, and duration of treatment. We 
propose a single-blinded RCT comparing the effects of Medical Qigong to light exercise 
on sleep disturbance in female BCS who are within six months to five years past 
completion of primary treatment for breast cancer. Adding to the literature of this 
treatment modality will inform patients on effective means of quality of life improvement 
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CHAPTER 3: STUDY METHODOLOGY 
3.1 STUDY DESIGN 
The study design will be a two-arm, single-blinded RCT.  
3.2 STUDY POPULATION AND SAMPLING  
 Participants will be sampled on a non-random, consecutive basis via convenience 
sampling from multiple sites including the Tumor Registry from Yale New Haven 
Hospital York Street Campus and Yale New Haven Hospital Saint Raphael Campus in 
New Haven, Connecticut. Participants will also be recruited from Sisters’ Journey 
support group, breast and survivorship clinics, and private oncology practices, all in New 
Haven, CT, if meeting the study criteria.  
See Table 1 for a complete list of inclusion and exclusion criteria. At baseline, 
participants will complete the PSQI and only those scoring above a 5 on Global Sleep 
Quality, indicating the presence of sleep disturbance, will be included in the study. 
Subjects will also complete the FACT-B, the FACIT-Sp, the FACT-ES, and the IPAQ at 
baseline. There will be a baseline characteristics enrollment survey completed upon 
enrollment.   
Table 1. Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria  
Female age ≥ 18 years old 
Clinical diagnosis of breast cancer stages 
0-III 
 
6 months to 5 years past completion of 
primary cancer treatment (surgery, 
Diagnosis of a concurrent medical 
condition likely to influence short-term 
survival 
 
History of a major psychiatric illness 





radiation, chemotherapy, or endocrine 
therapy) 
 
No evidence of cancer recurrence  
Ability to read and write in English  
Physically capable of participating in 
exercise 
 
A score of >5 in Global Sleep Quality on 
the PSQI 
Current alcohol or drug dependence 
 
Practice of Qigong or Tai Chi within the 
last year 
 
Physical disabilities including an inability 
to walk unassisted, chronic pain while 
walking, or difficulty walking for 20 mins 
 
3.3 SUBJECT PROTECTION AND CONFIDENTIALITY   
 The clinical site will be IRB approved under the Yale Human Investigations 
Committee (HIC). All research staff will undergo Health Insurance Portability and 
Accessibility Act (HIPAA) training before the start of the study. Any protected health 
information (PHI) will only be accessed by HIPAA-trained research staff and only 
accessed through university-approved secure electronic health records (EHR) on 
encrypted devices. A partial waiver of authorization under HIPAA will be requested to 
access the Tumor Registry PHI. Each participant will be provided with the details of the 
study as well as risks, benefits, and statements of confidentiality. They will be given an 
opportunity to read and ask questions regarding the most updated IRB approved 
Authorization and Consent form (Appendix A), and will be asked to give written, signed 
consent.  
3.4 RECRUITMENT 
 The primary recruitment process will include the use of the hospital Tumor 
Registry from Yale New Haven Hospital York Street Campus and Yale New Haven 
Hospital Saint Raphael Campus which will generate a list of eligible subjects. We will 
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use passive physician consent for this recruitment strategy. The provider of each subject 
will be contacted via a letter from the primary investigator. The provider will be asked to 
identify any patients who should not be approached for the study. If providers do not 
identify patients not to contact within two weeks, the research staff will contact subjects 
from the Tumor Registry list to determine interest in participation. Additional recruitment 
will involve the distribution of flyers to the Sister’s Journey support group, breast and 
survivorship clinics, and Yale Cancer Center Community Care practices.  
Interested participants will be evaluated by research staff for eligibility. Research 
staff will provide information about the study including risks and benefits and schedule 
an appointment for informed consent and baseline assessments. Recruitment and 
enrollment into the study will take place over nine months on an ongoing basis.    
3.5 STUDY VARIABLES AND MEASURES 
Qigong Intervention: The Qigong intervention will consist of two, 60-minute group 
sessions per week for 12 weeks. Participants will be encouraged to practice at home 
outside of sessions using materials provided. Groups will consist of 12 people and will 
take place at various community centers in New Haven, CT led by accredited Qigong 
instructors. The intervention will be based on seven movements: “Preparatory Form”, 
“Lazy About Tying Coat”, “Fist Under Elbow”, “Step Back and Whirl Arms on Both 
Sides”, “Part Horse’s Mane”, “Wave Hands Through Clouds”, and “Close”.1 Sample 
Qigong movements can be viewed in Figure 1. The length of meditations during class 
will increase throughout the 12 weeks to build experience with the practice and attempt to 
reap the most benefits. Each session will include a 5-minute warm up, 40 minutes of 
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Qigong exercise, and 5 minutes of relaxation at the end. A 10-minute break will be 
provided mid-way through the 40-minute exercise session. 
Figure 1. Sample Qigong Movements  
 
Chang PS, Knobf MT, Oh B, Funk M. Physical and psychological effects of Qigong exercise in 
community-dwelling older adults: An exploratory study. Geriatr Nurs. 2018;39(1):88-94. 
 
Active Control: The light exercise program will consist of group exercise classes 
matched for the time of the Qigong intervention: two, 60-minute sessions per week for 12 
weeks. Participants will be given materials and encouraged to practice their exercises at 
home on off days. The program will be implemented in groups of 12 and will be led by a 
trained exercise physiologist. Exercises will focus on light resistance training and 
stretching with a mild aerobic component matching the level of exertion and movement 
expected in the Qigong group. Stretching exercises will align with the targeted muscle 
groups of that day’s training. The light exercise group will also be conducted at 
community centers in New Haven, CT, but at different locations than the Qigong group 
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as to not allow the two groups to have a chance of seeing the other intervention. The 
active control will have the opportunity to enroll in Qigong classes equivalent to our 
intervention at the conclusion of the study free of charge.  
Adherence to Assigned Intervention: Adherence to the interventions will be 
ensured using documented attendance at each session as well as at assessment points. 
Instructors at each session will pass around an attendance sheet. Additionally, research 
staff will conduct random observations of sessions of each group to ensure intervention 
fidelity. Participants in both groups will be asked to log hours of exercise outside of 
group classes. Participants will be encouraged to discontinue their usual exercise routine 
during the study.  
Primary and Secondary Outcomes: The primary outcome measure for this study is 
sleep disturbance as measured by the PSQI (Appendix B). A Fitbit Alta HR will measure 
objective sleep parameters including total sleep time (TST, min), sleep efficiency (SE, 
%), wake after sleep onset (WASO, min), and sleep onset latency (SOL, min). These 
objective outcomes will be considered secondary outcome measures. Fitbits will be given 
to participants at the onset of study free of charge and participants will wear them 
overnight the night before each assessment point. Other secondary outcomes include 
quality of life in the five remaining dimensions as presented in the Layers Model of 
Qigong—mental, emotional, social, and spiritual—and will be measured using the FACT-
B and the FACIT-Sp.  
Baseline Variables: At baseline participants will complete an enrollment survey 
which will ask patients about age, cancer stage at diagnosis, time since treatment, type of 
treatment, treatment with endocrine therapy, education level, income, menopausal status, 
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BMI, and insurance coverage. Baseline characteristics will also be gathered through the 
EHR if a participant is unsure of an answer. Participants will complete the PSQI, FACT-
B, and FACIT-Sp at baseline; they will also complete the FACT-ES and the IPAQ to 
assess baseline endocrine symptoms and physical activity, respectively.  
3.6 BLINDING OF INTERVENTION AND OUTCOME 
Blinding of intervention: Due to the nature of the intervention it is not possible to 
blind participants or instructors to both groups. However, participants will be blinded to 
the hypothesis as well as to the alternative group for the duration of the study. Instructors 
will also be blinded to the hypothesis and will only be informed that the study is for 
improvement in lifestyle for BCS. Participants will be instructed not to discuss their 
intervention when undergoing assessments.  
Blinding of Outcome: The study will follow a single-blinded approach where 
investigators and outcome assessors will be blinded to allocation at baseline and each 
assessment point.  
3.7 ASSIGNMENT OF INTERVENTION  
Upon enrollment, participants will complete baseline assessments and then be 
randomized to intervention. A computerized random number generator will randomize 
patients with 1:1 allocation to intervention or control. Investigators and other staff will be 
blind to allocation as each allocation will be concealed in a sequentially numbered, 




3.8 DATA COLLECTION  
Subjects will complete the IPAQ and FACT-ES at baseline and all remaining 
questionnaires at baseline, at the end of the 12-week intervention, and again at 3 months 
and 6 months follow up. The 6-month follow up timepoint will allow researchers to 
assess the lasting effects of the Qigong intervention in our population. Participants will 
retrieve Fitbits at enrollment and wear them overnight at home the night before each 
assessment point. The next day upon questionnaire assessment participants will return 
Fitbits to research staff for data collection and receive them back before leaving. 
Research staff will be trained on each questionnaire and on Fitbit software, and will score 
each tool at every time point.  
3.9 SAMPLE SIZE CALCULATION 
A simple t-test calculator Power and Precision version 4.0 (Biostat Inc.) was used to 
look for a difference in means for an anticipated effect size of 3.6 units on the PSQI with 
a standard deviation of 3.6, though the actual test will be a fixed-effects model. A sample 
size of 32 participants per arm is needed to provide 90% power. To account for multiple 
comparisons, we are adjusting the alpha to 0.01 with a Bonferroni adjustment for 
multiple comparisons between groups and the effects of time interaction. The final 
sample size will account for an estimated 10% dropout rate and thus a total of 36 
participants will be randomized to each arm for a total of 72 participants in the study 
(Appendix C).  
3.10 ANALYSIS  
 Descriptive statistics of baseline characteristics will be run. Continuous variables 
including age and time since cancer treatment completion will be reported as means and 
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standard deviations. A student t-test will be used to compare continuous variables at 
baseline. Relative frequencies will be used for categorical variables including income, 
race, insurance status, employment status, education level, cancer treatment type, 
menopausal state, and other chronic health conditions including diabetes, hypertension, 
hypo- or hyperthyroidism, and any autoimmune disorders. Comparisons between 
categorical variables will be conducted using a chi-square test.  
Outcome data will be analyzed using an intention-to-treat analysis. Baseline 
scores on the PSQI, FACT-B, FACIT-Sp, IPAQ, and FACT-ES will be compared 
between groups using a student t-test. Baseline data from the initial night sleeping with 
the Fitbit (i.e. TST, WASO, SOL all measured in minutes, and SE measured as a 
percentage) will also be compared between groups with a student t-test. The primary 
outcome of this study, mean change in sleep disturbance as measure by the PSQI, will be 
operationalized as a continuous variable. To determine the statistical significance of the 
effect of Qigong versus light exercise, we will use hierarchical linear mixed-effects 
models to assess the independent effects of the intervention group (either Qigong or light 
exercise) and time (baseline, post-intervention, 3-month follow up, and 6-month follow 
up) for the primary and secondary outcomes. The baseline measurement for each 
outcome variable will be the reference value for time, with fixed effects for post-
intervention, 3-month follow up, and 6-month follow up. There will be three, time by 
intervention interaction terms since there will be three fixed effects for time (post-
intervention, 3-month follow-up, a 6-month follow up).  
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3.11 TIMELINE AND RESOURCES  
The timeline of the proposed study can be found in Figure 2. The proposed study 
will take place within two years. Training of research staff and coordination with 
intervention sites will take place over the first 3 months. Recruitment of participants for 
the study will take place over the next 9 months. The intervention will be 3 months. 
Follow up assessments will occur at the end of the intervention, at 3 months, and at 6 
months after completion of the intervention. Data analysis and manuscript preparation 
will take place within 6 months of study completion.  
 The principal investigator (PI) for the study will be M. Tish Knobf, PhD, RN, 
FAAN and the co-principal investigator (co-PI) will be Elisabeth Mirenda, PA-SII. 
Research assistants and statisticians at Yale University will be recruited to help conduct 
the study and will be trained in the scoring of each assessment tool, as well as in the use 
and scoring of Fitbit software. Qigong instructors and exercise physiologists will be 
recruited from the region and compensated for their time. Before the start of the study 
and within the first 3 months, the PI and co-PI will approach community centers within 
the New Haven, CT area to request the use of facilities for the study. Participants will be 
provided with a Fitbit device at enrollment and will be asked to wear the device overnight 
the night before each assessment. Participants will be compensated with a $20 Visa gift 
card at every assessment point and free parking at study sites. Participants will be given 
the opportunity to keep the Fitbit device at the end of the study if desired.  
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CHAPTER 4: CONCLUSION 
4.1 ADVANTAGES AND DISADVANTAGES  
 This study will be the first to use an RCT design to compare the practice of 
Qigong to light exercise with a focus on improving sleep in BCS. Unlike previous studies 
that have lacked an active control group, our study will potentially gain insight into the 
unique properties of the practice of Qigong and its multidimensional effects by directly 
comparing it to an active exercise control.1,2 Through a randomized controlled design, we 
hope to gain insight into the benefits of Qigong by minimizing selection bias and 
potential bias from confounding variables. Unlike previously discussed studies that have 
been limited in sample size and single sites, we hope to extend the generalizability of our 
results by gaining a larger sample size and conducting the study at more than one 
research site.1,2 By recruiting patients from the Sisters’ Journey support group we will 
create a more heterogeneous sample in order to further improve the generalizability of 
results. Finally, providing both a subjective and objective measure of sleep will allow 
researchers to gain a better understanding with more robust evidence as to the efficacy of 
our intervention on sleep.  
 There are some limitations to the proposed study that must be considered. First, 
the single-blinded design presents the possibility for participants to be biased in regards 
to their intervention placement. By blinding participants to the hypothesis and to the 
comparison group we will attempt to minimize adverse effects on results. There is a 
possibility that the length of the intervention of 12 weeks may not be long enough to 
provide lasting effects from the Qigong intervention and future studies may consider 
providing a longer outcome. However, this study is designed to prevent drop out and the 
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length of 12 weeks should help control for it. Our study recommends that women 
discontinue their normal exercise routine upon enrollment, yet it is not possible to 
completely limit women from partaking in other exercises outside of their assigned 
intervention. We will attempt to control for this potential limitation by running the IPAQ 
questionnaire on baseline physical activity. 
By using a subjective measure of sleep quality in our population, there is an 
opportunity for participants to influence their responses by overestimating or 
underestimating aspects of their sleep habits. We will attempt to control for this form of 
response bias by initiating a concurrent objective measure of sleep with the Fitbit device. 
It must be noted that previous studies have demonstrated inconsistencies between 
subjective and objective measures of sleep.3 However, none of these studies utilized the 
Fitbit device as an objective measure and rather involved either PSG or actigraphy. In 
this study the Fitbit will only be worn at assessment points (four times throughout the 
study) for one night at a time, whereas the PSQI will ask for information regarding at 
least the previous 30 days of sleep. This could potentially provide inconsistencies 
between these two measures. The Fitbit has not been widely studied as an objective 
measure of sleep, especially in cancer populations as it is still a new device used for 
sleep. However, this study poses an opportunity to increase knowledge and data 
regarding the device and sleep. Finally, the Fitbit device is a user-dependent device; there 
will be those who are familiar and those who are unfamiliar with the device. The device 
also may not be user-friendly to older women who are less familiar with the technology. 
As with any study utilizing technology, these limitations must be considered when 
analyzing results.   
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4.2 CLINICAL AND PUBLIC HEALTH SIGNIFICANCE  
 Breast cancer diagnosis and treatment can adversely affect women’s physical, 
psychological, emotional, social, and spiritual well-being and can last for years after 
diagnosis. With improved survival, providers will be treating increasingly more women 
with post-treatment side effects and comorbidities that affect quality of life, and women 
will be seeking treatment options for them. It is important that providers are equipped 
with evidence-based guidelines for symptom management. Insurance companies may be 
more inclined to pay for alternative treatment modalities when the literature is more 
robust regarding their efficacy. If the findings of this study improve sleep and quality of 
life in BCS, providers will have evidence for an alternative sleep and healthy lifestyle 
behavior to recommend. Qigong is accessible and easy to learn for all ages and abilities. 
Previous studies have compared Qigong to CBT-I and future studies should consider 
comparing Qigong to medical treatments and how it could be beneficial to implement 
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APPENDIX A: AUTHORIZATION AND CONSENT FORM 
 
COMPOUND AUTHORIZATION AND CONSENT FOR PARTICIPATION IN A 
RESEARCH PROJECT 
YALE UNIVERSITY SCHOOL OF MEDICINE  
YALE NEW HAVEN HOSPITAL  
 
Study Title: Medical Qigong Versus Exercise on Sleep Disturbance and Quality of Life 
in Breast Cancer Survivors  
 
Principal Investigator: M. Tish Knobf, PhD, RN, FAAN 
Co-Investigator: Elisabeth Mirenda, PA-SII 
Funding Source: Yale University School of Medicine Physician Associate Program  
 
Invitation to Participate and Description of Project 
 
You are invited to participate in a research study investigating sleep and other aspects of 
quality of life in breast cancer survivors using two different types of exercise-based 
interventions. You have been asked to participate because you have a history of a 
diagnosis of breast cancer and began treatment within the last year. Approximately 72 
women with breast cancer will participate in this study.  
 
In order to decide whether or not you wish to be a part of this research study you should 
know enough about its risks and benefits to make an informed decision. This consent 
form gives you detailed information about the research study, which a member of the 
research team will discuss with you. This discussion should go over all aspects of the 
research: its purpose, the procedures that will be performed, any risks of the procedures, 
possible benefits, and possible alternative treatments. Once you understand the study, you 
will be asked if you wish to participate; if so, you will be asked to sign this form.  
 
Description of Procedures  
 
If you agree to participate in this study, you will be randomly assigned to one of two 
types of exercise classes in groups of 10-15 people. Random assignment is like flipping a 
coin with a 50/50 chance of one group or the other. You will be asked to attend an hour 
class twice per week for 12 weeks. You will also be encouraged to work on what you 
have learned in class at home on your days off. These classes will take place at 
community centers in the New Haven, CT area. Parking will be free of charge. You will 
be asked to log your exercise time outside of class. You will receive reminder calls or 
texts for sessions from a research assistant. Randomization will be done by a computer 
program and will not be based on any personal baseline information. During the course of 




At the start of the study, you will complete 5 questionnaires regarding your sleep habits 
and other aspects of your physical, emotional, and psychological well-being. You will 
also complete these questionnaires at the end of the 12-week exercise course, and at visits 
3 and 6 months after the end of the course. You will be compensated for attendance to 
assessment visits in the form of a $20 Visa gift card at each assessment point. 
 
You will be asked to wear a Fitbit wristband device overnight on 4 different nights 
throughout the study. Fitbits will be worn the night before your assessment visit at the 
start of the study, after the 12-week intervention, and at the 3- and 6-month visits. They 
will be returned to research staff at your assessment visit. Information taken from Fitbits 
will include heart rate, respiratory rate, and sleep time. You will be allowed to keep the 
Fitbit at the end of the study if you desire.  
 
You will be told of any significant new findings that are developed during the course of 
your participation in this study that may affect your willingness to continue to participate. 
Research results will not be returned to your doctor. If research results are published, 
your name and other personal information will not be given.  
 
Risks and Inconveniences 
 
We do not anticipate any major risks in participating in this study. Due to our 
intervention being based on basic exercise principles and a decrease in physical activity 
among women after breast cancer therapy, there is a potential risk for some side effects 
such as muscle aches or strained muscles. Though risks of negative outcomes are small, 
our interventions may make participants more aware of psychosocial factors in their lives 
and emotional distress. We can provide referrals to appropriate providers if needed.  
 
There is a risk of breach of confidentiality about your health status and participation in 
this study, though this is unlikely to occur. All research staff will be thoroughly trained 




Benefits of participation in this study may include improvements in mental, emotional, 
social, and spiritual health, improvements in sleep, and improvements in physical health. 
This study may also provide information on how to integrate complementary therapy, 
such as non-strenuous exercise, into daily lives.  
 
Economic Consideration  
 
Exercise classes will be provided free of charge. Parking at facilities will be free. You 
will be compensated at each assessment visit in the form of a $20 Visa gift card. Upon 
completion of the study you will be gifted the Fitbit device if you desire to keep it. 
 




The alternative to participating in this study is to decline participation. If you do not wish 
to participate you will be provided the standard treatment for sleep-related issues at the 
discretion of your healthcare provider.  
 
Confidentiality and Privacy  
 
Any identifiable information that is obtained in connection with this study will remain 
confidential and will be disclosed only with your permission or as permitted by U.S. or 
state law. Examples of information that we are legally required to disclose include abuse 
of a child or elderly person, or certain reportable diseases. Information will be kept 
confidential by using only identification numbers on study forms, storing signed forms in 
locked cabinets, and password protecting data stored on a computer. When the results of 
the research are published or discussed in conferences, no information will be included 
that would reveal your identity unless your specific permission for this activity is 
obtained.  
 
We understand that information about your health is personal, and we are committed to 
protecting the privacy of the information. If you decide to be in this study, the researcher 
will get information that identifies your personal health information. This may include 
information that might directly identify you, such as your name, birth date, or address. 
This information will be de-identified at the earliest reasonable time after we receive it, 
meaning we will replace your identifying information with a code that does not directly 
identify you. The principal investigator will keep a link that identifies you and your 
coded information, and this link will be kept secure and available only to the principal 
investigator or selected members of the research team. Any information that can identify 
you will remain confidential. The link to your personal information will be kept for 5 
years, after which time the link will be destroyed and the data will become anonymous. 
The data will be kept in this anonymous form indefinitely.  
 
The information about your health that will be collected in this study includes:  
 
• Research study records 
• Records about phone calls made as part of this research  
• Records about your study visits 
 
Information about you and your health which might identify you may be used by or given 
to: 
 
Representatives from Yale University, the Yale Human Research Protection Program, 
and the Yale Human Investigation Committee (the committee that reviews, approves, and 
monitors research on human subjects), who are responsible for ensuring research 
compliance. These individuals are required to keep all information confidential.  
 
By signing this form, you authorize the use and /or disclosure of the information 
described above for this research study. The purpose of the uses and disclosures you are 
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authorizing is to ensure that the information relating to this research is available to all 
parties who may need it for research purposes.  
 
All health care providers subject to HIPAA (Health Insurance Portability and 
Accountability Act) are required to protect the privacy of your information. The research 
staff at the Yale School of Medicine and those hospitals involved in this study are 
required to comply with HIPAA and to ensure the confidentiality of your information. 
You have the right to review and copy your health information in your medical record in 
accordance with institutional medical records policies. This authorization to use and 
disclose your health information collected during your participation in this study will 
never expire.  
 
Voluntary Participation and Withdrawal  
 
Participation in this study is voluntary. You are free to choose not to take part in this 
study. Refusing to participate will involve no penalty or loss of benefits to which you are 
otherwise entitled (such as your health care outside the study, the payment for your health 
care, and your health care benefits). However, you will not be able to enroll in this 
research study and will not receive study procedures as a study participant if you do not 
allow use of your information as part of this study.  
 
Withdrawing from the Study 
 
If you do become a subject of this study, you are free to stop and withdraw at any time 
during its course.  
 
To withdraw from the study, you can call a member of the research team at any time and 
tell them that you no longer wish to participate. This will cancel any future appointments. 
Withdrawing from the study will involve no penalty or loss of benefits to which you are 
otherwise entitled. You may withdraw or take away your permission to use and disclose 
your health information at any time. If you withdraw your permission, you will not be 
able to stay in this study. When you withdraw your permission, no new health 
information identifying you will be gathered after that date. Information that has already 
been gathered may still be used and given to others until the end of the research study, as 
necessary, to ensure the integrity of the study and/or study oversight.  
 




We have used some technical terms in this form. Please feel free to ask about anything 
you do not understand and to consider this research and the consent form carefully—as 






Authorization and Permission:  
I have read (or someone has read to me) this form and have decided to participate in the 
project described above. Its general purpose, the particulars of my involvement, and 
possible hazards and inconveniences have been explained to my satisfaction. My 
signature also indicates that I have received a copy of this consent form.  
By signing this form, I give permission to the researchers to use [and give out] 
information about me for the purpose described in this form. By refusing to give 
permission, I understand that I will not be able to be in this research study.  
 




_______________________________________            _______________ 




_______________________________________            ________________ 
Signature of Person Obtaining Consent                           Date  
 
If after you have signed this form you have any questions about your privacy rights, 
please contact the Yale Privacy Officer at (203) 432-5919. 
 
If you have further questions about this project or if you have a research-related problem, 
you may contact the co-Principal Investigator, Elisabeth Mirenda. If you would like to 
talk with someone other than the researchers to discuss problems, concerns, and questions 
you may have concerning this research, or to discuss your rights as a research subject, 







APPENDIX B: SAMPLE PSQI 
 
The Pittsburg Sleep Quality Index (PSQI) 
Instructions: The following questions relate to your usual sleep habits during the past 
month only. Your answers should indicate the most accurate reply for the majority of 
days and nights in the past month. Please answer all questions. During the past month: 
1. When have you usually gone to bed?  
2. How long (in minutes) has it taken you to fall asleep each night?  
3. When have you usually gotten up in the morning?  
4. How many hours of actual sleep do you get at night? (This may be different than 
the number of hours you spend in bed)  
Choose: Not during the past month (0), Less than once a week (1), Once or twice a week 
(2), Three or more times a week (3) 
5. During the past month, how often have you had trouble sleeping because you… 
a. Cannot get to sleep within 30 minutes  
b. Wake up in the middle of the night or early morning 
c. Have to get up to use the bathroom  
d. Cannot breathe comfortably  
e. Cough or snore loudly  
f. Felt too cold  
g. Felt too hot  
h. Have bad dreams  
i. Have pain  
j. Other reason(s), please describe, including how often you have had trouble 
sleeping because of this reason(s): 
6. During the past month, how often have you taken medicine (prescribed or “over 
the counter”) to help you sleep?  
7. During the past month, how often have you had trouble staying awake while 
driving, eating meals, or engaging in social activity?  
8. During the past month, how much of a problem has it been for you to keep up 
enthusiasm to get things done?  
Choose: Very good (0), Fairly good (1), Fairly bad (2), Very bad (3) 
9. During the past month, how would you rate your sleep quality overall?  
Component 1: #9 score_____ 
Component 2: #2 score (≤15 min=0; 16-30 min=1; 31-60 min=2, >60 min=3) + #5a   
                       score (If sum is equal 0=0; 1-2=1; 3-4=2; 5-6=3) _____ 
 
Component 3: #4 Score (>7=0; 6-7=1; 5-6=2; <5=3) ______ 
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Component 4: (total # of hours asleep)/ (total # of hours in bed) x 100; 
                        >85%=0, 75%-84%=1, 65%-74%=2, <65%=3______ 
 
Component 5: Sum of Scores #5b to #5j (0=0; 1-9=1; 10-18=2; 19-27=3) _____ 
 
Component 6: #6 score _____ 
 
Component 7: #7 score + #8 score (0=0; 1-2=1; 3-4=2; 5-6=3) ______ 
 
Add the seven component scores together. Global PSQI Score: ________ 
 
 
Permission has been granted to reproduce, post, download, and/or distribute, this material 
in its entirety for not-for-profit educational purposes by the Hartford Institute for 
Geriatric Nursing, New York University, College of Nursing. 
Buysse, D.J., Reynolds III, C.F., Monk, T.H., Berman, S.R., & Kupfer, D.J. (1989). The  
Pittsburgh Sleep Quality Index: A new instrument for psychiatric  practice and 


















APPENDIX C: SAMPLE SIZE CALCULATION 
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